Showing 461-470 of 3134 results for "".
How Aesthetic Surgeons Can Capitalize on Neglected Sources of Competitive Advantage
https://modernaesthetics.com/ma-issues-index/2017-mar-apr/how-aesthetic-surgeons-can-capitalize-on-neglected-sources-of-competitive-advantage/34294/A few neglected sources of competitive advantage represent significant opportunities for practitioners willing to pioneer new ways to achieve differentiation in an increasingly competitive marketplace.MATV News: Allergan Acquires Zeltiq; The Formula for Attractive Lips
https://modernaesthetics.com/series/matv-news/matv-news-allergan-acquires-zeltiq-the-formula-for-attractive-lips/33348/Acquisitions top aesthetic news with Allergan acquiring Zeltiq and Hologic buying Cynosure along with rumors that Syneron is on the block. What do these acquisitions mean for the field? Also in this episode, new research assesses what measurements create the most attractive female lips and we look aAll In One
https://modernaesthetics.com/ma-issues-index/2017-jan-feb/all-in-one/34312/How one expert distilled diverse training, rich clinical and life experiences, and the challenges of practice management down to a simplified and rewarding approach to aesthetic practice.MATV News: New Natrelle Inspira Implants from Allergan; RT002 Trials for Frown Lines
https://modernaesthetics.com/series/matv-news/matv-news-new-natrelle-inspira-implants-from-allergan-rt002-trials-for-frown-lines/33350/The FDA has approved Allergan's Natrelle Inspira SoftTouch breast implants. Two double-blind, placebo-controlled Phase 3 trials are now underway to evaluate daxibotulinumtoxinA (RT002) from Revance Therapeutics for the treatment of glabellar lines. Also, Venus Concept is bringing its Venus VelocityMATV News: New Restylane Fillers FDA Approved; Hyperhidrosis and Anxiety; Educating Plastic Surgery Patients
https://modernaesthetics.com/series/matv-news/new-restylane-fillers-fda-approved-hyperhidrosis-and-anxiety-educating-plastic-surgery-patients/33400/The FDA approved two new Galderma Restylane fillers for the treatment of nasolabial folds or laugh lines in patients over the age of 21. Patients with hyperhidrosis may be more likely to be anxious or depressed and you may want to council cosmetic surgery patients to stop prior to undergoing proceduAnnuities: Obtaining a Fixed Income for Life
https://modernaesthetics.com/ma-issues-index/2016-nov-dec/annuities-obtaining-a-fixed-income-for-life/34332/Owning the right annuity will allow you to receive funds for the rest of your life, regardless of whether you outlive your initial investment.MATV News: Juvéderm Volbella XC Now Available; Gluteal Fat Grafting Task Force Forms
https://modernaesthetics.com/series/matv-news/matv-news-juv-derm-volbella-xc-now-available-gluteal-fat-grafting-task-force-forms--estovege/33356/Juvéderm Volbella XC is now available for lip augmentation and correction of perioral rhytids. Also, the Aesthetic Surgery Education and Research Foundation forms a Gluteal Fat Grafting Task Force in response to high mortality rates seen with Brazilian butt lifts, Biologica Technologies introduces iFight Commoditization: Dos and Don'ts for Aesthetic Physicians
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/fight-commoditization-dos-and-donts-for-aesthetic-physicians/34350/You have the power to overcome commoditization. Take the right steps to be active, not reactive.There's an App for That… Or Is There?
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/theres-an-app-for-that-or-is-there/34361/Don't Quit Your Day Job and Other Smart Steps for Aspiring DevelopersThe Most Valuable Asset You're Ignoring: Why Internal Marketing Is the Smartest (and Least Expensive) Way to Grow Your Practice
https://modernaesthetics.com/ma-issues-index/2016-july-aug/the-most-valuable-asset-youre-ignoring-why-internal-marketing-is-the-smartest-and-least-expensive-way-to-grow-your-practice/34375/Your existing relationships are your most valuable asset.